| AMPK | 5’ adenosine monophosphate-activated protein kinase |
| ATM | Ataxia-telangiectasia mutated kinase |
| Bad | Bcl-2−associated death promoter protein |
| BAX | Bcl-2−associated x gene |
| Bcl-2 | B-cell lymphoma 2 |
| Bcl-XL | B-cell lymphoma-extra large |
| BGLAP3 | Bone γ-carboxyglutamate protein 3 |
| BMSCs | Bone marrow stem cells |
| BRCA1 | Breast cancer type 1 susceptibility gene |
| CASP3 | Caspase-3 gene |
| CASP9 | Caspase-9 gene |
| CDK-2 | Cyclin-dependent kinase-2 |
| FOXO3a | Forkhead Box O3a protein |
| HA | Hydroxyapatite |
| MMP-9 | Matrix metallopeptidase-9 |
| MnTMPyP | Manganese(iii) tetrakis(1-methyl-4-pyridyl)porphyrin |
| MSeA | Methyseleninic acid |
| NO | Nitric oxide |
| NPC | Nutritional Prevention of Cancer trial |
| Nrf2 | Nuclear factor erythroid 2−related factor 2 |
| O2−• | Superoxide anion |
| PARP | Poly(ADP-ribose) polymerase |
| PLLA | Poly-l-lactic acid |
| pTEN | Tumour suppressor protein phosphatase and tensin homolog |
| ROS | Reactive oxygen species |
| RSeOH | Seleninic acid |
| SeC | Selenocysteine |
| SeHA | Seo32−-containing HA |
| SeHA/ALG | Selenium-containing Hydroxyapatite/Alginate |
| SeHA/ALG RIS I | Seha/AIG granules with risedronate sodium during formation |
| SeHA/ALG RIS II | Seha/AIG granules with risedronate sodium and potassium chloride during formation |
| SeHAN | Selenite-substituted HA nanoparticles |
| SeMet | Selenomethionine |
| Se-MSC | Selenium-methylselenocysteine |
| SeNP-PLLA | Selenium-coated poly-l-lactic acid nanocomposites |
| SeO2 | Selenium dioxide |
| SeO32− | Selenite |
| SeO42− | Selenate |
| Se-Poly | Selenium-polysaccharide |
| Ser | Serine |
| tBid | Truncated BH3 interacting-domain death agonist protein |
| WRN | Werner syndrome protein |
| γH2Ax | Phosphorylated H2A histone family member x |